{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for "JECFA Evaluation|Functional Classification|ANTIOXIDANT SYNERGIST" in comments (approximate match)
Showing 1 - 1 of 1 results
Status:
US Approved Rx
(2023)
Source:
ANDA216435
(2023)
Source URL:
First approved in 1953
Source:
CALCIUM DISODIUM VERSENATE by BAUSCH
Source URL:
Class (Stereo):
CHEMICAL (ACHIRAL)
Conditions:
Edetic acid (EDTA) is a chelating agent. The U.S. Food and Drug Administration (FDA) approved edetic acid chelation therapy as a treatment for lead and heavy metal poisoning. Edetic acid in form of disodium salt was withdrawn from the market due to death resulting from hypocalcemia during chelation.
